Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Freudenberg Expands Biopharm Product Portfolio with Addition of Custom Single-Use Assemblies

August 06, 2024

Freudenberg Medical has introduced custom single-use assemblies for silicone extrusion and molding for biopharma applications.

Webcasts

Evaluating Aseptic Processing and Manufacturing

August 06, 2024

Webinar Date/Time: Thu, Aug 29, 2024 11:00 AM EDT

Frontrunners in Automated Cell and Gene Therapy Manufacturing

August 04, 2024

Innovative solutions are making personalized cell and gene therapies accessible to all.

Dual Shaft Mixers with Multi-Agitator System

August 01, 2024

The ROSS FDA-3500 dual shaft mixer is equipped with independently controlled drives and is designed to efficiently produce good turnover and impart shear to a viscous batch.

Next-Generation Tablet Press

August 01, 2024

The NexGen Press 45 is the latest member of GEA Pharma & Healthcare’s NexGen Press line of tablet presses.

New Protein Production Platform

August 01, 2024

Syngene’s protein production platform uses a cell line and transposon-based technology licensed from Switzerland-based ExcellGene.

Scorpius Holdings Prepares for Mammalian CGMP Manufacturing Campaign Launch in Texas Facility

July 27, 2024

Scorpius Holdings is set to launch its first CGMP manufacturing campaign at its San Antonio, Texas, facility for mammalian cell culture in the 2024 third quarter.

BeiGene Opens New Jersey-Based Biologics Manufacturing and Clinical R&D Site

July 26, 2024

BeiGene has opened its new $800 million Hopewell, NJ-based biologics manufacturing facility, which also houses the company's clinical R&D capabilities.

Univercells and University of Pennsylvania Expand Agreement for Gene Therapy Program

July 25, 2024

Univercells and the University of Pennsylvania are expanding their collaboration to evaluate certain bioreactors with the aim to scale up gene therapy manufacturing.

Kadimastem and Pluri Enter Cell Therapy Manufacturing Deal

July 20, 2024

PluriCDMO, Pluri's newly launched CDMO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.